21 results
8-K
EX-99.4
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
insurance and benefits and was intended to broaden access to health care coverage, enhance remedies against fraud and abuse, add transparency requirements … implementing regulations, including the Final Omnibus Rule;
the federal transparency requirements known as the federal Physician Payments Sunshine Act, created
8-K
EX-99.3
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
.
Fraud and Abuse, Data Privacy and Security, and Transparency Laws and Regulations
Although Elicio currently does not have any products … designed to, among other things, bring more transparency to product pricing, review the
relationship between pricing and manufacturer patient programs
424B3
ELTX
Elicio Therapeutics Inc.
28 Apr 23
Prospectus supplement
4:07pm
and was intended to broaden access to health care coverage, enhance remedies against fraud and abuse, add transparency requirements for the health care … , including the Final Omnibus Rule;
the federal transparency requirements known as the federal Physician Payments Sunshine Act, created as part of the ACA
S-4/A
osx4i5ezhwnm2j3gq4
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.32
zj9q4a19k
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
10-Q
ykzceor
17 May 21
Quarterly report
6:03am
10-K
0on i20vqm84ch
30 Mar 21
Annual report
5:00pm
424B4
obk76j4zo
5 Feb 21
Prospectus supplement with pricing info
5:12pm
DRS/A
44fllqsd3fr15at
15 Dec 20
Draft registration statement (amended)
12:00am